DK200400365A - Anvendelse af et progestogen og et østrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt - Google Patents
Anvendelse af et progestogen og et østrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt Download PDFInfo
- Publication number
- DK200400365A DK200400365A DK200400365A DKPA200400365A DK200400365A DK 200400365 A DK200400365 A DK 200400365A DK 200400365 A DK200400365 A DK 200400365A DK PA200400365 A DKPA200400365 A DK PA200400365A DK 200400365 A DK200400365 A DK 200400365A
- Authority
- DK
- Denmark
- Prior art keywords
- estrogen
- progestogen
- acetate
- estradiol
- norethindrone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Description
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK200400365A DK175317B1 (da) | 1983-08-05 | 2004-03-04 | Anvendelse af et progestogen og et östrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52083483A | 1983-08-05 | 1983-08-05 | |
US52083483 | 1983-08-05 | ||
US63523684 | 1984-07-27 | ||
US06/635,236 US4826831A (en) | 1983-08-05 | 1984-07-27 | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
DK198403770A DK165390C (da) | 1983-08-05 | 1984-08-03 | Anvendelse af et progestogen og et østrogen til fremstllling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt |
DK377084 | 1984-08-03 | ||
DK200400365 | 2004-03-04 | ||
DK200400365A DK175317B1 (da) | 1983-08-05 | 2004-03-04 | Anvendelse af et progestogen og et östrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt |
Publications (2)
Publication Number | Publication Date |
---|---|
DK200400365A true DK200400365A (da) | 2004-03-04 |
DK175317B1 DK175317B1 (da) | 2004-08-16 |
Family
ID=27060286
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198403770A DK165390C (da) | 1983-08-05 | 1984-08-03 | Anvendelse af et progestogen og et østrogen til fremstllling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt |
DK200400365A DK175317B1 (da) | 1983-08-05 | 2004-03-04 | Anvendelse af et progestogen og et östrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198403770A DK165390C (da) | 1983-08-05 | 1984-08-03 | Anvendelse af et progestogen og et østrogen til fremstllling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt |
Country Status (12)
Country | Link |
---|---|
US (2) | US4826831A (da) |
EP (1) | EP0136011B2 (da) |
AT (1) | ATE147987T1 (da) |
CA (1) | CA1240927A (da) |
DE (5) | DE19775086I2 (da) |
DK (2) | DK165390C (da) |
IL (1) | IL72556A (da) |
LU (5) | LU90107I2 (da) |
MX (1) | MX9203720A (da) |
NL (5) | NL970026I1 (da) |
NZ (1) | NZ209066A (da) |
PH (1) | PH24052A (da) |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4961931A (en) * | 1982-07-29 | 1990-10-09 | Alza Corporation | Method for the management of hyperplasia |
US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
IE61236B1 (en) * | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
CH674618A5 (da) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
ES2024010B3 (es) * | 1987-07-06 | 1992-02-16 | Akzo Nv | Unidad de dosis farmaceutica. |
US4900734A (en) * | 1987-08-27 | 1990-02-13 | Maxson Wayne S | Novel pharmaceutical composition containing estradiol and progesterone for oral administration |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
EP0322020A1 (en) * | 1987-12-22 | 1989-06-28 | Akzo N.V. | Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis |
HUT52382A (en) * | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
GB8813353D0 (en) * | 1988-06-06 | 1988-07-13 | Ici Plc | Therapeutic product |
ES2077675T3 (es) * | 1989-03-10 | 1995-12-01 | Endorecherche Inc | Terapia combinada para el tratamiento de enfermedades sensibles a los estrogenos. |
US5043331A (en) * | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
ZA924811B (en) * | 1991-06-28 | 1993-12-29 | Endorecherche Inc | Controlled release systems and low dose androgens |
HU222501B1 (hu) * | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására |
IL107343A (en) * | 1992-11-02 | 2003-10-31 | Wyeth Corp | PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN |
ZA94715B (en) * | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
US5710144A (en) * | 1993-02-08 | 1998-01-20 | Akzo Nobel N.V. | C-11 substituted steroids for treating menopausal complaints |
US6037339A (en) | 1993-02-08 | 2000-03-14 | Akzo Nobel N.V. | C-11 substituted steroids for treating menopausal complaints |
DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
US5759577A (en) * | 1995-01-17 | 1998-06-02 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
DE19510861A1 (de) * | 1995-03-16 | 1996-09-19 | Schering Ag | Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen |
US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
WO1997004752A1 (en) * | 1995-07-26 | 1997-02-13 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions of conjugated estrogens and methods for their use |
FR2737411B1 (fr) * | 1995-08-01 | 1997-10-17 | Theramex | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
US5654011A (en) * | 1996-07-30 | 1997-08-05 | Energetics, Inc. | Dietary supplements |
US6040333A (en) * | 1996-07-30 | 2000-03-21 | Energetics, Inc. | Dietary supplements |
US5807586A (en) * | 1996-07-30 | 1998-09-15 | Energetics, Inc. | Method of dietary supplementation |
FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
AU4957999A (en) * | 1998-07-17 | 2000-02-07 | Pharmacia & Upjohn Company | Subcutaneous medroxyprogesterone acetate for contraception |
US6165504A (en) * | 1998-09-23 | 2000-12-26 | Barr Laboratories, Inc. | Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients |
AU1197100A (en) * | 1998-10-09 | 2000-05-01 | Pharmacia & Upjohn Company | Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
US6613758B1 (en) | 1999-04-02 | 2003-09-02 | Barr Laboratories, Inc. | Method for treating osteoporosis in castrated prostatic cancer patients |
US6703367B1 (en) | 1999-04-27 | 2004-03-09 | Praecis Pharmaceuticals Inc. | Methods for treating hot flashes and gynaecomastia |
US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
WO2001030356A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
US7025979B2 (en) | 2000-02-15 | 2006-04-11 | Schering Ag | Male contraceptive formulation comprising norethisterone |
US7459445B2 (en) * | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
US6660726B2 (en) | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
US7989436B2 (en) | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
US20010034340A1 (en) * | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
US20020151530A1 (en) * | 2000-12-22 | 2002-10-17 | Leonard Thomas W. | Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
DE10100911A1 (de) * | 2001-01-11 | 2002-08-01 | Schering Ag | Verfahren zur Hormonersatztherapie und dessen Darreichungsform |
US20060142257A1 (en) * | 2001-01-19 | 2006-06-29 | Eberhard Nieschlag | Male contraceptive formulation comprising norethisterone |
WO2002074292A2 (en) * | 2001-03-16 | 2002-09-26 | Wyeth | Hormone replacement therapy |
CA2441252A1 (en) * | 2001-03-16 | 2002-10-10 | Wyeth | Estrogen replacement therapy |
FR2823976A1 (fr) * | 2001-04-25 | 2002-10-31 | Theramex | Nouvelle composition hormonale et son utilisation |
US20130203722A1 (en) | 2006-09-26 | 2013-08-08 | Rhonda R. Voskuhl | Estriol therapy for autoimmune and neurodegenerative disease and disorders |
CA2446849A1 (en) | 2001-05-16 | 2002-11-21 | Endeavor Pharmaceuticals | Treatment of conditions relating to hormone deficiencies by administration of progestins |
EP1406634A1 (en) * | 2001-07-13 | 2004-04-14 | Schering Aktiengesellschaft | Combination of drospirenone and an estrogen sulphamate for hrt |
WO2003018026A1 (en) * | 2001-08-31 | 2003-03-06 | Pantarhei Bioscience B.V. | Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
EP1453521B1 (en) | 2001-12-05 | 2013-09-04 | Teva Women's Health, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
US20030216366A1 (en) * | 2002-04-03 | 2003-11-20 | Leonard Thomas W. | Step-down estrogen therapy |
US20030191096A1 (en) * | 2002-04-03 | 2003-10-09 | Leonard Thomas W. | Method of hormonal therapy |
TW200306851A (en) * | 2002-04-29 | 2003-12-01 | Wyeth Corp | Hormone replacement therapy |
TW200404551A (en) * | 2002-05-17 | 2004-04-01 | Wyeth Corp | Hormone replacement therapy |
TW200400040A (en) * | 2002-05-17 | 2004-01-01 | Wyeth Corp | Hormone replacement therapy |
ES2277139T3 (es) * | 2002-08-28 | 2007-07-01 | Robert Casper | Regimen de reposicion de estrogenos. |
EP1462106A1 (en) * | 2003-03-28 | 2004-09-29 | Pantarhei Bioscience B.V. | Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders |
US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
CA2521471A1 (en) * | 2003-04-11 | 2004-10-28 | Barr Laboratories, Inc. | Methods of administering estrogens and progestins |
US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
AU2004257772B2 (en) * | 2003-07-16 | 2009-12-17 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
ES2933479T3 (es) * | 2003-09-29 | 2023-02-09 | Novo Nordisk Healthcare Ag | Estabilidad mejorada de formulaciones de progestágenos |
DK1670440T3 (da) | 2003-09-29 | 2014-07-07 | Novo Nordisk As | HRT formuleringer |
AU2005249401A1 (en) * | 2004-05-26 | 2005-12-15 | Wyeth | Compositions and methods for treatment of premenstrual dysphoric disorder |
DE102004026669A1 (de) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels |
DE102004026679A1 (de) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat |
US20060040904A1 (en) * | 2004-08-17 | 2006-02-23 | Ahmed Salah U | Vaginal cream compositions, kits thereof and methods of using thereof |
US20070111975A1 (en) * | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
EP1853272A1 (en) * | 2005-02-03 | 2007-11-14 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
EP1971325A2 (en) * | 2005-12-27 | 2008-09-24 | Duramed Pharmaceuticals, Inc. | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
US20080242650A1 (en) * | 2007-03-26 | 2008-10-02 | Jean-Louis Thomas | Oral contraceptive regimen |
EP2164498A4 (en) | 2007-06-04 | 2010-09-08 | Univ California | PREGNANCY HORMONE ASSOCIATION FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
BR112012026115B1 (pt) | 2010-04-15 | 2019-12-24 | Bayer Ip Gmbh | forma de dosagem oral sólida, seu uso, e unidade de acondicionamento |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10369158B2 (en) | 2014-04-28 | 2019-08-06 | The Regents Of The University Of California | Pharmaceutical packaging for estriol therapy |
US10799512B2 (en) | 2014-04-28 | 2020-10-13 | The Regents Of The University Of California | Estrogen combination for treatment of multiple sclerosis |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
WO2016036719A1 (en) | 2014-09-02 | 2016-03-10 | The Regents Of The University Of California | Estrogen therapy for brain gray matter atrophy and associated disability |
US9962395B2 (en) | 2014-09-29 | 2018-05-08 | The Regents Of The University Of California | Compositions and methods for maintaining cognitive function |
US10406169B2 (en) | 2015-03-30 | 2019-09-10 | The Regents Of The University Of California | Methods of monitoring estriol therapy |
PE20231714A1 (es) | 2015-06-18 | 2023-10-23 | Estetra Sprl | Unidad de dosificacion orodispersable que contiene un componente estetrol |
UA123098C2 (uk) | 2015-06-18 | 2021-02-17 | Естетра Спрл | Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3639600A (en) * | 1969-08-28 | 1972-02-01 | Upjohn Co | Process of establishing cyclicity in a human female |
US3733407A (en) * | 1971-08-25 | 1973-05-15 | Syntex Corp | Menopause treatment |
US3836651A (en) * | 1972-02-22 | 1974-09-17 | Biolog Concepts Inc | Novel oral contraceptive combination |
DE2365103C3 (de) * | 1973-12-21 | 1980-08-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | V erwendung von Hormonen zur Kontrazeption |
US4018919A (en) * | 1975-07-16 | 1977-04-19 | Eli Lilly And Company | Sequential contraceptive method using two types of progestational agents |
DE2645307A1 (de) * | 1976-10-05 | 1978-04-06 | Schering Ag | Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen |
GB1578340A (en) * | 1977-11-15 | 1980-11-05 | Normalair Garrett Ltd | Mechanical hands eg for diving apparatus |
US4425339A (en) * | 1981-04-09 | 1984-01-10 | Syntex (U.S.A.) Inc. | Treatment of menopausal symptoms |
-
1984
- 1984-07-27 US US06/635,236 patent/US4826831A/en not_active Ceased
- 1984-07-31 IL IL72556A patent/IL72556A/xx not_active IP Right Cessation
- 1984-07-31 CA CA000460073A patent/CA1240927A/en not_active Expired
- 1984-07-31 NZ NZ209066A patent/NZ209066A/en unknown
- 1984-08-02 DE DE1997175086 patent/DE19775086I2/de active Active
- 1984-08-02 DE DE10199001C patent/DE10199001I2/de active Active
- 1984-08-02 EP EP84305260A patent/EP0136011B2/en not_active Expired - Lifetime
- 1984-08-02 DE DE10075037C patent/DE10075037I2/de active Active
- 1984-08-02 AT AT84305260T patent/ATE147987T1/de active
- 1984-08-02 DE DE10199010C patent/DE10199010I2/de active Active
- 1984-08-02 DE DE3486442T patent/DE3486442T3/de not_active Expired - Lifetime
- 1984-08-03 DK DK198403770A patent/DK165390C/da active Protection Beyond IP Right Term
- 1984-08-03 PH PH31063A patent/PH24052A/en unknown
-
1992
- 1992-06-29 MX MX9203720A patent/MX9203720A/es active IP Right Grant
-
1995
- 1995-10-13 US US08/542,941 patent/USRE36247E/en not_active Expired - Lifetime
-
1997
- 1997-07-21 LU LU90107C patent/LU90107I2/fr unknown
- 1997-07-22 NL NL970026C patent/NL970026I1/nl unknown
- 1997-10-22 NL NL970037C patent/NL970037I2/nl unknown
-
1998
- 1998-11-20 NL NL980038C patent/NL980038I2/nl unknown
-
1999
- 1999-01-27 LU LU90343C patent/LU90343I2/fr unknown
-
2000
- 2000-10-23 NL NL300022C patent/NL300022I2/nl unknown
- 2000-12-13 LU LU90696C patent/LU90696I2/fr unknown
- 2000-12-13 LU LU90697C patent/LU90697I2/fr unknown
-
2001
- 2001-01-04 NL NL300033C patent/NL300033I2/nl unknown
-
2004
- 2004-03-04 DK DK200400365A patent/DK175317B1/da active Protection Beyond IP Right Term
- 2004-07-30 LU LU91096C patent/LU91096I2/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK200400365A (da) | Anvendelse af et progestogen og et østrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt | |
KR960001371B1 (ko) | 폐경기 전의 여성용 혼합 제형 및 이를 포함하는 팩 | |
KR100186780B1 (ko) | 피임제제 | |
Regidor et al. | Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone | |
NO316257B1 (no) | Anvendelse av en sammensetning av et östrogen og et gestagen, og et enfasetkombinasjonsprodukt for oral prevensjon | |
CA2267743A1 (en) | Low dose estrogen interrupted hormone replacement therapy | |
KR890004723A (ko) | 호르몬 제제 및 이의 제조방법 | |
JP2000502108A (ja) | ゲストゲンとエストロゲン併用によるほ乳動物の避妊法とキット | |
ATE271386T1 (de) | Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält | |
WO2002094281A1 (en) | Means and method for hormonal contraception | |
BR9710565A (pt) | Contraceptivo oral | |
JP2005530791A (ja) | 結合型エストロゲンとトリメゲストンの組み合わせを用いたホルモン補充療法 | |
WO2002094277A1 (en) | Means and method for hormonal contraception | |
JP2005527574A (ja) | ホルモン補充療法におけるトリメゲストンと組み合わせた結合型エストロゲンの使用 | |
JP2005527577A (ja) | ホルモン補充療法 | |
Elstein | Oral contraception reviewed | |
DK200101066A (da) | Farmaceutisk præparat til hormonbehandling | |
MXPA01010976A (es) | Uso de antiprogestagenos en terapia combinada. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CTFF | Application for supplementary protection certificate (spc) filed |
Free format text: PRODUCT NAME: ESTRADIOL, NORETHISTERONACETAT Spc suppl protection certif: CA 2004 00022 Filing date: 20040802 Expiry date: 20090803 Free format text: PRODUCT NAME: NORETHISTERONACETAT, ETHINYLESTRADIOL Spc suppl protection certif: CA 2004 00023 Filing date: 20040802 Expiry date: 20090803 |
|
PUP | Patent expired | ||
CTFG | Supplementary protection certificate (spc) issued |
Free format text: PRODUCT NAME: NORETHISTERONACETAT, ETHINYLESTRADIOL Spc suppl protection certif: CA 2004 00023 Filing date: 20040802 |
|
CTFG | Supplementary protection certificate (spc) issued |
Free format text: PRODUCT NAME: ESTRADIOL, NORETHISTERONACETAT Spc suppl protection certif: CA 2004 00022 Filing date: 20040802 |